Article ; Online: Maternal and cord blood BAFF and APRIL levels during pregnancy.
American journal of reproductive immunology (New York, N.Y. : 1989)
2022 Volume 89, Issue 3, Page(s) e13654
Abstract: Problem: Dysregulation of factors vital to the survival B cells and/or plasma cells, such as BAFF and APRIL, could be detrimental to a pregnancy.: Method of study: Serially collected first-, second-, and third-trimester serum samples were measured ... ...
| Abstract | Problem: Dysregulation of factors vital to the survival B cells and/or plasma cells, such as BAFF and APRIL, could be detrimental to a pregnancy. Method of study: Serially collected first-, second-, and third-trimester serum samples were measured for BAFF and APRIL by ELISA from 150 pregnant women (71 healthy + 79 with a chronic medical disease) at a single medical center. Postpartum serum samples were also collected from the majority of these women. Matched third-trimester and cord blood samples were collected from 168 women (86 healthy + 82 with a chronic medical disease). Data were analyzed by chi-square statistic, unpaired t-test, paired t-test, Mann-Whitney rank sum test, Wilcoxon signed rank test, Spearman rank order correlation, and receiver operator characteristic (ROC) curve analyses as appropriate. Results: Maternal serum BAFF levels declined as the pregnancies progressed and rebounded postpartum, whereas serum APRIL levels remained relatively flat throughout pregnancy and postpartum. Cord BAFF and APRIL levels correlated positively with gestation age and were considerably greater than the corresponding maternal third-trimester serum BAFF and APRIL levels, respectively. In women who developed preeclampsia, third-trimester BAFF levels were greater, rather than lower, than their corresponding second-trimester BAFF levels. ROC curve analysis suggested a potential role for third-trimester serum BAFF level as a biomarker of preeclampsia. Conclusions: BAFF and APRIL are differentially regulated in the mother during and following pregnancy, whereas each is upregulated in the developing fetus. An increase in third-trimester serum BAFF level may portend development of preeclampsia. |
|---|---|
| MeSH term(s) | Pregnancy ; Female ; Humans ; Pre-Eclampsia ; Fetal Blood ; Pregnancy Trimester, Third ; Pregnancy Trimester, Second ; Biomarkers |
| Chemical Substances | TNFSF13 protein, human ; Biomarkers |
| Language | English |
| Publishing date | 2022-11-24 |
| Publishing country | Denmark |
| Document type | Journal Article |
| ZDB-ID | 604542-x |
| ISSN | 1600-0897 ; 0271-7352 ; 8755-8920 ; 1046-7408 |
| ISSN (online) | 1600-0897 |
| ISSN | 0271-7352 ; 8755-8920 ; 1046-7408 |
| DOI | 10.1111/aji.13654 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 1653: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.